Inflammatory Diseases Completed Phase 1 Trials for Lanraplenib (DB14770)

Also known as: Inflammatory Disease

IndicationStatusPhase
DBCOND0041144 (Inflammatory Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02959138Pharmacokinetics of Lanraplenib in Adults With Impaired Renal FunctionTreatment